A.A. Khalil Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

University of Arkansas at Fayetteville

unknown

4 pubs

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

A.A. Khalil's research has focused on analyzing existing medical literature to identify trends and risk factors. Recent publications include a bibliometric analysis of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) polymorphism and its association with atherosclerosis, published in 2025. Also in 2025, Khalil co-authored a publication on the efficacy of palbociclib combined with endocrine therapy versus chemotherapy in premenopausal women with specific types of breast cancer. Previously, Khalil investigated risk factors for radiation pneumonitis in modern adaptive radiotherapy and the predictive value of early response to chemotherapy in non-small cell lung cancer, with publications in 2022.

Metrics

  • Publications: 4

Selected Publications

  • Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Polymorphism with Atherosclerosis: A Bibliometric Analysis (2025) DOI

Similar Researchers

Based on overlapping research topics